BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36150053)

  • 1. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
    Krischer JP; Lynch KF; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2017 Sep; 40(9):1194-1202. PubMed ID: 28646072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
    Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
    Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.
    Vandewalle J; Desouter AK; Van der Auwera BJ; Tenoutasse S; Gillard P; De Block C; Keymeulen B; Gorus FK; Van de Casteele M;
    Clin Exp Immunol; 2023 Mar; 211(3):224-232. PubMed ID: 36622793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
    Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
    J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
    Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
    JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.
    Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J;
    Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
    Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
    Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetologia; 2021 Oct; 64(10):2247-2257. PubMed ID: 34291312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
    Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
    J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.